Cambridge Nutritional Sciences plc
CNSL.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -14.8% | 29.5% | -11.6% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 60.1% | 61.9% | 42% | 55.6% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | -£0 | -£0 | -£0 | -£0 |
| Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -7.7% | -5.5% | -36.8% | -6.8% |
| Other Income/Exp. Net | £0 | -£0 | -£0 | -£0 |
| Pre-Tax Income | £0 | -£0 | -£0 | -£0 |
| Tax Expense | £0 | -£0 | -£0 | £0 |
| Net Income | £0 | -£0 | -£0 | -£0 |
| % Margin | 18.8% | -3.4% | -51.2% | -132.7% |
| EPS | 0.007 | -0.001 | -0.017 | -0.062 |
| % Growth | 571.4% | 91.6% | 73.1% | – |
| EPS Diluted | 0.007 | -0.001 | -0.017 | -0.062 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | £0 | -£0 | -£0 | -£0 |
| % Margin | 26.4% | -0.7% | -35.1% | -4.5% |